Logo image of AXS.AS

ACCSYS TECHNOLOGIES PLC (AXS.AS) Stock Fundamental Analysis

AMS:AXS - Euronext Amsterdam - GB00BQQFX454 - Common Stock - Currency: EUR

0.746  +0.01 (+0.81%)

Fundamental Rating

3

AXS gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 11 industry peers in the Paper & Forest Products industry. AXS has a bad profitability rating. Also its financial health evaluation is rather negative. AXS is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

AXS had negative earnings in the past year.
In the past year AXS had a positive cash flow from operations.
In multiple years AXS reported negative net income over the last 5 years.
Each year in the past 5 years AXS had a positive operating cash flow.
AXS.AS Yearly Net Income VS EBIT VS OCF VS FCFAXS.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M -40M

1.2 Ratios

AXS has a worse Return On Assets (-12.63%) than 72.73% of its industry peers.
The Return On Equity of AXS (-23.48%) is worse than 72.73% of its industry peers.
Looking at the Return On Invested Capital, with a value of 3.81%, AXS is in line with its industry, outperforming 45.45% of the companies in the same industry.
Industry RankSector Rank
ROA -12.63%
ROE -23.48%
ROIC 3.81%
ROA(3y)-12.79%
ROA(5y)-7.46%
ROE(3y)-23.46%
ROE(5y)-13.64%
ROIC(3y)N/A
ROIC(5y)N/A
AXS.AS Yearly ROA, ROE, ROICAXS.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20 -30

1.3 Margins

AXS has a Operating Margin of 5.60%. This is in the better half of the industry: AXS outperforms 63.64% of its industry peers.
AXS's Operating Margin has improved in the last couple of years.
AXS has a Gross Margin of 30.32%. This is in the lower half of the industry: AXS underperforms 63.64% of its industry peers.
AXS's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 5.6%
PM (TTM) N/A
GM 30.32%
OM growth 3Y14.91%
OM growth 5Y30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y0.04%
AXS.AS Yearly Profit, Operating, Gross MarginsAXS.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 30

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AXS is destroying value.
AXS has more shares outstanding than it did 1 year ago.
The number of shares outstanding for AXS has been increased compared to 5 years ago.
The debt/assets ratio for AXS is higher compared to a year ago.
AXS.AS Yearly Shares OutstandingAXS.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
AXS.AS Yearly Total Debt VS Total AssetsAXS.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

2.2 Solvency

AXS has an Altman-Z score of 1.02. This is a bad value and indicates that AXS is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.02, AXS is doing worse than 63.64% of the companies in the same industry.
The Debt to FCF ratio of AXS is 6.79, which is on the high side as it means it would take AXS, 6.79 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 6.79, AXS perfoms like the industry average, outperforming 54.55% of the companies in the same industry.
A Debt/Equity ratio of 0.55 indicates that AXS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.55, AXS is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 6.79
Altman-Z 1.02
ROIC/WACC0.5
WACC7.55%
AXS.AS Yearly LT Debt VS Equity VS FCFAXS.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

2.3 Liquidity

AXS has a Current Ratio of 2.11. This indicates that AXS is financially healthy and has no problem in meeting its short term obligations.
AXS's Current ratio of 2.11 is amongst the best of the industry. AXS outperforms 81.82% of its industry peers.
AXS has a Quick Ratio of 1.09. This is a normal value and indicates that AXS is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of AXS (1.09) is better than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.11
Quick Ratio 1.09
AXS.AS Yearly Current Assets VS Current LiabilitesAXS.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M

4

3. Growth

3.1 Past

The earnings per share for AXS have decreased strongly by -20.07% in the last year.
AXS shows a small growth in Revenue. In the last year, the Revenue has grown by 0.34%.
AXS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.49% yearly.
EPS 1Y (TTM)-20.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%204.35%
Revenue 1Y (TTM)0.34%
Revenue growth 3Y4.18%
Revenue growth 5Y8.49%
Sales Q2Q%-0.85%

3.2 Future

The Earnings Per Share is expected to grow by 34.82% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 5.63% on average over the next years.
EPS Next Y106.75%
EPS Next 2Y51.82%
EPS Next 3Y34.82%
EPS Next 5YN/A
Revenue Next Year9.47%
Revenue Next 2Y12.15%
Revenue Next 3Y10.81%
Revenue Next 5Y5.63%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AXS.AS Yearly Revenue VS EstimatesAXS.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 50M 100M 150M
AXS.AS Yearly EPS VS EstimatesAXS.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2022 2023 2024 2025 2026 2027 2028 0 0.05 -0.05 -0.1

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AXS. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 93.45, which means the current valuation is very expensive for AXS.
Compared to the rest of the industry, the Price/Forward Earnings ratio of AXS is on the same level as its industry peers.
AXS's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.76.
Industry RankSector Rank
PE N/A
Fwd PE 93.45
AXS.AS Price Earnings VS Forward Price EarningsAXS.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXS is valued a bit cheaper than the industry average as 63.64% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of AXS is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 20.31
EV/EBITDA 13.07
AXS.AS Per share dataAXS.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AXS's earnings are expected to grow with 34.82% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.82%
EPS Next 3Y34.82%

0

5. Dividend

5.1 Amount

No dividends for AXS!.
Industry RankSector Rank
Dividend Yield N/A

ACCSYS TECHNOLOGIES PLC

AMS:AXS (7/3/2025, 1:27:32 PM)

0.746

+0.01 (+0.81%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryPaper & Forest Products
Earnings (Last)06-24 2025-06-24/amc
Earnings (Next)11-24 2025-11-24
Inst Owners39.04%
Inst Owner ChangeN/A
Ins Owners0.37%
Ins Owner ChangeN/A
Market Cap179.35M
Analysts86
Price Target0.01 (-98.66%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-98.87%
PT rev (3m)-98.86%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)55%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.58%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 93.45
P/S 1.31
P/FCF 20.31
P/OCF 16.73
P/B 1.84
P/tB 1.97
EV/EBITDA 13.07
EPS(TTM)-0.1
EYN/A
EPS(NY)0.01
Fwd EY1.07%
FCF(TTM)0.04
FCFY4.92%
OCF(TTM)0.04
OCFY5.98%
SpS0.57
BVpS0.4
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -12.63%
ROE -23.48%
ROCE 5.08%
ROIC 3.81%
ROICexc 4.3%
ROICexgc 4.51%
OM 5.6%
PM (TTM) N/A
GM 30.32%
FCFM 6.46%
ROA(3y)-12.79%
ROA(5y)-7.46%
ROE(3y)-23.46%
ROE(5y)-13.64%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y33.54%
ROICexcg growth 5Y42.93%
ROICexc growth 3Y34.09%
ROICexc growth 5Y43.81%
OM growth 3Y14.91%
OM growth 5Y30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.59%
GM growth 5Y0.04%
F-Score5
Asset Turnover0.76
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 6.79
Debt/EBITDA 3.17
Cap/Depr 20.49%
Cap/Sales 1.38%
Interest Coverage 3.87
Cash Conversion 63.55%
Profit Quality N/A
Current Ratio 2.11
Quick Ratio 1.09
Altman-Z 1.02
F-Score5
WACC7.55%
ROIC/WACC0.5
Cap/Depr(3y)140.37%
Cap/Depr(5y)274.36%
Cap/Sales(3y)7.53%
Cap/Sales(5y)14.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-20.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%204.35%
EPS Next Y106.75%
EPS Next 2Y51.82%
EPS Next 3Y34.82%
EPS Next 5YN/A
Revenue 1Y (TTM)0.34%
Revenue growth 3Y4.18%
Revenue growth 5Y8.49%
Sales Q2Q%-0.85%
Revenue Next Year9.47%
Revenue Next 2Y12.15%
Revenue Next 3Y10.81%
Revenue Next 5Y5.63%
EBIT growth 1Y832.66%
EBIT growth 3Y19.71%
EBIT growth 5Y41.18%
EBIT Next Year245.48%
EBIT Next 3Y68.44%
EBIT Next 5YN/A
FCF growth 1Y137.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.95%
OCF growth 3Y67.8%
OCF growth 5Y35.14%